Connor, Clark & Lunn Investment Management Ltd.

Position in TECX — Tectonic Therapeutic, Inc.

CIK 1596800 VANCOUVER, A1

Position in TECX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,232,637

+$161,853 QoQ

Shares Held

64,940

-3.1% QoQ

Ownership

0.332%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#34

of 122 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $650,455,383 across 105 Biotechnology names. TECX ranks #46 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	135,236	$67,175,777
2	IONS	Ionis Pharmaceuticals Inc	684,236	$54,253,072
3	ARWR	Arrowhead Pharmaceuticals, Inc.	625,569	$50,990,129
4	MIRM	Mirum Pharmaceuticals, Inc.	420,063	$49,176,775
5	REGN	Regeneron Pharmaceuticals, Inc.	42,465	$26,478,625
6	AXSM	Axsome Therapeutics, Inc.	97,698	$23,913,539
7	INSM	INSMED Inc	212,676	$22,675,515
8	VKTX	Viking Therapeutics, Inc.	530,607	$20,698,979

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,232,637	64,940	-3.1%	Shares	Sole	2026-08-13
2026-03-31	$2,070,784	66,994	-6.5%	Shares	Sole	2026-05-11
2025-12-31	$1,494,765	71,657	+63.3%	Shares	Sole	2026-02-10
2025-09-30	$688,555	43,885	+22.9%	Shares	Sole	2025-11-13
2025-06-30	$709,517	35,708	+3.1%	Shares	Sole	2025-08-07
2025-03-31	$613,562	34,645	+139.2%	Shares	Sole	2025-05-12
2024-12-31	$668,772	14,485	+88.1%	Shares	Sole	2025-02-10
2024-09-30	$233,370	7,702	—	Shares	Sole	2024-11-08
No filing history on record for this holder in this stock.